Beliefs about FDA tobacco regulation, modifiability of cancer risk, and tobacco product comparative harm perceptions: Findings from the HINTS-FDA 2015

Prev Med. 2018 May:110:1-8. doi: 10.1016/j.ypmed.2018.01.011. Epub 2018 Jan 31.

Abstract

Smokers who inaccurately believe that FDA evaluates cigarettes for safety hold lower harm perceptions of cigarettes compared to those who do not hold this belief. However, not much is known about associations between beliefs about FDA tobacco regulatory authority and comparative harm perceptions of tobacco products. Data were analyzed from the Health Information National Trends Survey, HINTS-FDA 2015 (N = 3738), which is a cross-sectional, probability-based, nationally representative survey of U.S. non-institutionalized civilian adults aged 18 years or older. Weighted multinomial and logistic regression analyses regressed comparative harm perceptions on sociodemographic factors, beliefs about FDA regulatory authority, perceptions of FDA credibility, and beliefs about modifiability of cancer risk (behavioral cancer causal beliefs and cancer fatalism). Findings indicate that, compared to non-users, current tobacco users are more likely to report believing that e-cigarettes are less harmful than cigarettes, to report believing that some cigarette types may be less harmful than others, and to report believing that tobacco products are safer now than they were five years ago. Awareness of FDA regulatory authority was associated with reporting the belief that tobacco products are safer now than five years ago, that e-cigarettes are less harmful than cigarettes, and that some cigarette types are less harmful than other cigarette types. Believing behavior as a cause of cancer and endorsing cancer fatalism were associated with uncertainty of comparative harm perceptions. Communication efforts can help target inaccurate beliefs by raising awareness about regulation of tobacco products as well as the risks of tobacco products.

Keywords: Causal attributions; FDA regulation; Risk perceptions; Tobacco.

MeSH terms

  • Adult
  • Awareness*
  • Cross-Sectional Studies
  • Female
  • Harm Reduction / drug effects*
  • Health Surveys
  • Humans
  • Male
  • Neoplasms* / epidemiology
  • Neoplasms* / etiology
  • Risk Factors
  • Smoking / adverse effects
  • Tobacco Products / adverse effects
  • Tobacco Products / legislation & jurisprudence*
  • United States / epidemiology
  • United States Food and Drug Administration / legislation & jurisprudence*